Surrogate Clinical End Points for Breast Cancer Screening Using Digital Breast Tomosynthesis
- PMID: 35103543
- DOI: 10.1148/radiol.213026
Surrogate Clinical End Points for Breast Cancer Screening Using Digital Breast Tomosynthesis
Comment on
-
A Randomized Trial Comparing Breast Cancer Incidence and Interval Cancers after Tomosynthesis Plus Mammography versus Mammography Alone.Radiology. 2022 May;303(2):256-266. doi: 10.1148/radiol.211132. Epub 2022 Feb 1. Radiology. 2022. PMID: 35103537 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical